Doctors Changing Approach to Common Heart Attack Treatment 

Naturopathic News

According to a study out of the University of Michigan Health System, doctors are reportedly changing practice trends as the debate continues on the optimal time to administer antiplatelet therapy.

Using the antiplatelet agents P2Y12 is becoming less routine. For instance, across 47 Michigan hospitals over a 30-month period, the initial administration of P2Y12 inhibitors in the pre-procedural time period declined from 49.3 percent to 24.8 percent. Seemingly, the trend has been to administer the initial dose of the inhibitor during or after the procedures. Their patients have remained protected against stent thrombosis, bleeding, the need for transfusion and death.

The study included 74,053 patients over a two and a half year period. The researchers thought it was important to note that, “These findings remained consistent in the subgroup of patients undergoing PCI who presented with acute coronary syndrome, from unstable angina to the most damaging heart attacks called STEMI.”

Of the 24,733 patients who received a pre-procedural P2Y12 inhibitor, data shows 82 percent received clopidogrel, eight percent prasugrel and 10 percent ticagrelor. When these inhibitors should be administered continues to be a topic that is debated.

One doctor notes, “While more work is needed to determine the optimal timing in patients undergoing PCI, the current approach of increasingly reserving the use of these drugs after the patient enters the cath lab appears to be as effective and safe as pre-procedural administration.”

 


raziRazi Berry, Founder and Publisher of Naturopathic Doctor News & Review (ndnr.com) and NaturalPath (thenatpath.com), has spent the last decade as a natural medicine advocate and marketing whiz. She has galvanized and supported the naturopathic community, bringing a higher quality of healthcare to millions of North Americans through her publications. A self-proclaimed health-food junkie and mother of two; she loves all things nature, is obsessed with organic gardening, growing fruit trees (not easy in Phoenix), laughing until she snorts, and homeschooling. She is a little bit crunchy and yes, that is her real name.

Current Issue

Table of Contents

Trending Articles

Restorative Formulations Launches the NeuroSynergy Clinical Series

Restorative Formulations Launches the NeuroSynergy Clinical Series

Four professional-grade formulas targeting distinct neurochemical pathways to support  mood, stress resilience, and cognitive function are now available exclusively to licensed  practitioners.  Montpelier, VT, March 27, 2026 — Restorative Formulations has released the...

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience Mitochondrial reserve capacity constrains the HPA, thyroid, and gonadal systems simultaneously, determining whether stress responses stay adaptive or consolidate into chronic dysfunction. When a...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Quantum Fields and Frequency Medicine

RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow...

Featured News